Circadian control of ROS homeostasis

ROS 稳态的昼夜节律控制

• 批准号: 7788416
• 负责人: Roman V Kondratov
• 金额: $ 5.82万
• 依托单位: CLEVELAND STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-01 至 2012-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7788416
• 关键词: Acetylcysteine; Address; Aging; Antioxidants; Cardiovascular Diseases; Cell Culture Techniques; Cells; Circadian Rhythms; Clock protein; Data; Development; Diabetes Mellitus; Disease; Enzymes; Free Radicals; Gene Silencing; Heart Diseases; Homeostasis; Human; Hypertension; Knockout Mice; Longevity; Malignant Neoplasms; Mediating; Metabolic; Metabolism; Molecular; Molecular Weight; Monitor; Mus; Nitrogen; Non-Insulin-Dependent Diabetes Mellitus; Organism; Oxidative Stress; Oxygen; Pathology; Predisposition; Prevention; Process; Regulation; Respiratory Burst; Risk; Role; Signal Transduction; Small Interfering RNA; Stroke; Superoxide Dismutase; Syndrome; System; Time; Tissues; Wild Type Mouse; base; biological adaptation to stress; circadian pacemaker; in vivo; public health relevance; response; treatment strategy

DESCRIPTION (provided by applicant): Reactive oxygen and nitrogen species (ROS/RNS) serve as important regulators of cellular signaling, metabolism and other molecular responses. Intracellular levels of ROS/RNS are tightly controlled, because an elevated ROS level results in oxidative stress, which is considered a major determinant of pathologies such as heart diseases, stroke, diabetes and cancer. We have demonstrated that the circadian transcriptional factor BMAL1 is directly involved in the control of ROS/RNS homeostasis and oxidative stress response in mouse and human cells, presumably through the control of expression of major antioxidant enzymes: PRDX1, PRDX6 and SOD1. The importance of BMAL1 as a regulator of ROS homeostasis is further supported by the fact that BMAL1 deficiency in mice results in early aging syndrome - significantly reduced lifespan and development of multiple pathologies - and is accompanied by elevated levels of ROS in several tissues. The treatment of BMAL1-null mice with the low molecular weight antioxidant NAC (N-acetyl cysteine) extends their lifespan and ameliorates pathologies. We hypothesized that the circadian system regulates ROS/RNS homeostasis and antioxidant defense by controlling BMAL1 expression/activity. We will determine molecular mechanisms of BMAL1-dependent regulation of ROS homeostasis and role of the circadian clock in the control this process through the following Specific Aims: (A1) To investigate the role of BMAL1 transcriptional targets PRDX1, PRDX6 and SOD1 in the BMAL1-dependent control of ROS homeostasis. (A2) To investigate the influence of circadian proteins CLOCK and CRY1 on the BMAL1-dependent regulation of ROS homeostasis. (A3) To investigate BMAL1-dependent ROS homeostasis and antioxidant defense in vivo. PUBLIC HEALTH RELEVANCE: This project addresses the role of the circadian clock proteins in the defense of organism from harmful action of free radicals. The obtained results will help to understand molecular basis of development of such pathologies as heart diseases, stroke and diabetes, and to develop a rational strategy for treatment and prevention.

描述（由申请人提供）：活性氧和氮（ROS/RNS）是细胞信号传导、代谢和其他分子反应的重要调节剂。ROS/RNS的细胞内水平受到严格控制，因为升高的ROS水平导致氧化应激，这被认为是心脏病、中风、糖尿病和癌症等病理学的主要决定因素。 我们已经证明，昼夜节律转录因子BMAL 1是直接参与控制ROS/RNS稳态和氧化应激反应在小鼠和人类细胞，大概是通过控制主要的抗氧化酶的表达：PRDX 1，PRDX 6和SOD 1。BMAL 1作为ROS稳态调节剂的重要性进一步得到以下事实的支持：小鼠中的BMAL 1缺乏导致早期衰老综合征-显著缩短寿命和多种病理学的发展-并且伴随着几种组织中ROS水平的升高。用低分子量抗氧化剂NAC（N-乙酰半胱氨酸）治疗BMAL 1缺失小鼠延长了它们的寿命并改善了病理学。 我们假设昼夜节律系统通过控制BMAL 1的表达/活性来调节ROS/RNS稳态和抗氧化防御。我们将通过以下具体目的来确定BMAL 1依赖性调节ROS稳态的分子机制以及生物钟在控制该过程中的作用：（A1）研究BMAL 1转录靶点PRDX 1、PRDX 6和SOD 1在BMAL 1依赖性控制ROS稳态中的作用。(A2)研究昼夜节律蛋白CLOCK和BMAL 1对BMAL 1依赖的ROS稳态调节的影响。(A3)研究体内BMAL 1依赖的ROS稳态和抗氧化防御。 公共卫生相关性：该项目致力于生物钟蛋白在生物体防御自由基有害作用中的作用。这些结果将有助于了解心脏病、中风和糖尿病等疾病发展的分子基础，并制定合理的治疗和预防策略。